InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,667.20
(
0.64%
)
US TECH 100
19,822.40
(
-0.12%
)
Dow Jones
40,954.48
(
1.85%
)
Brent Oil
83.07
(
-0.30%
)
Bitcoin
65,482.86
(
0.60%
)

Replies to post #87045 on Biotech Values

Replies to #87045 on Biotech Values
icon url

genisi

07/26/10 9:44 AM

#99685 RE: genisi #87045

Carfilzomib achieved an ORR of 24% and a median duration of response of 7.4 months in that open label single arm phase IIb trial. Looks good enough for approval.